Related references
Note: Only part of the references are listed.PAR-1 contributes to the innate immune response during viral infection
Silvio Antoniak et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Protease-Activated Receptor-2 Regulates the Innate Immune Response to Viral Infection in a Coxsackievirus B3-Induced Myocarditis
Alice Weithauser et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Inflammatory Cytokines in Heart Failure: Mediators and Markers
Lars Gullestad et al.
CARDIOLOGY (2012)
Tissue inhibitor of metalloproteinases (TIMPs) in heart failure
Linn Moore et al.
HEART FAILURE REVIEWS (2012)
Alternatively spliced tissue factor and full-length tissue factor protect cardiomyocytes against TNF-α-induced apoptosis
U. Boltzen et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2012)
Tryptase activates isolated adult cardiac fibroblasts via protease activated receptor-2 (PAR-2)
David B. Murray et al.
JOURNAL OF CELL COMMUNICATION AND SIGNALING (2012)
Cardiac mast cells: the centrepiece in adverse myocardial remodelling
Scott P. Levick et al.
CARDIOVASCULAR RESEARCH (2011)
Tryptase/Protease-Activated Receptor 2 Interactions Induce Selective Mitogen-Activated Protein Kinase Signaling and Collagen Synthesis by Cardiac Fibroblasts
Jennifer L. McLarty et al.
HYPERTENSION (2011)
Fibrosis in endstage human heart failure: Severe changes in collagen metabolism and MMP/TIMP profiles
Victoria Polyakova et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2011)
Protease-activated Receptors and Myocardial Infarction
Silvio Antoniak et al.
IUBMB LIFE (2011)
Protease-Activated Receptor 2 Deficiency Reduces Cardiac Ischemia/Reperfusion Injury
Silvio Antoniak et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2010)
Heart Disease and Stroke Statistics-2009 Update A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Donald Lloyd-Jones et al.
CIRCULATION (2009)
Regulation of cardiomyocyte full-length tissue factor expression and microparticle release under inflammatory conditions in vitro
S. Antoniak et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
Active site inhibited factor VIIa attenuates myocardial ischemia/reperfusion injury in mice
S. T. B. G. Loubele et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
Agonist-Biased Signaling via Proteinase Activated Receptor-2: Differential Activation of Calcium and Mitogen-Activated Protein Kinase Pathways
Rithwik Ramachandran et al.
MOLECULAR PHARMACOLOGY (2009)
Adiponectin protects against angiotensin II-induced cardiac fibrosis through activation of PPAR-α
Koichi Fujita et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Protease-activated receptor-2 activation: a major actor in intestinal inflammation
E. Hyun et al.
GUT (2008)
Viral myocarditis and coagulopathy:: Increased tissue factor expression and plasma thrombogenicity
Silvio Antoniak et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2008)
Protease-activated receptor-1 contributes to cardiac remodeling and hypertrophy
Rafal Pawlinski et al.
CIRCULATION (2007)
PAR-2 activation at the time of reperfusion salvages myocardium via an ERK1/2 pathway in in vivo rat hearts
Rong Jiang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)
Proteinase-activated receptor-2 exerts protective and pathogenic cell type-specific effects in Alzheimer's disease
Amir Afkhami-Goli et al.
JOURNAL OF IMMUNOLOGY (2007)
Role of cardiac myocyte tissue factor in heart hemostasis
R. Pawlinski et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Induction of monocyte chemoattractant protein-1 release from A549 cells by agonists of protease-activated receptor-1 and -2
Haiyan Wang et al.
EUROPEAN JOURNAL OF CELL BIOLOGY (2007)
Tissue factor deficiency and PAR-1 deficiency are protective against renal ischemia reperfusion injury
Jacob Sevastos et al.
BLOOD (2007)
Mast cell deficient W/Wv mice have lower serum IL-6 and less cardiac tissue necrosis than their normal littermates following myocardial ischemia-reperfusion
K. Bhattacharya et al.
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2007)
Essential role of Rho/ROCK-dependent processes and actin dynamics in mediating leptin-induced hypertrophy in rat neonatal ventricular myocytes
Asad Zeidan et al.
CARDIOVASCULAR RESEARCH (2006)
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
SA Hunt et al.
CIRCULATION (2005)
Mast cell tryptase in mast cell granules enhances MCP-1 and interleukin-8 production in human endothelial cells
M Kinoshita et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
CCL2/monocyte chemoattractant protein-1 regulates inflammatory responses critical to healing myocardial infarcts
O Dewald et al.
CIRCULATION RESEARCH (2005)
Alterations in myocardial tissue factor expression and cellular localization in dilated cardiomyopathy
B Szotowski et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Deficiency of PAR-2 gene increases acute focal ischemic brain injury
G Jin et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2005)
Mast cell tryptase may modulate endothelial cell phenotype in healing myocardial infarcts
P Somasundaram et al.
JOURNAL OF PATHOLOGY (2005)
The cardiovascular actions of protease-activated receptors
SF Steinberg
MOLECULAR PHARMACOLOGY (2005)
Anti-monocyte chemoattractant protein-1 gene therapy attenuates left ventricular remodeling and failure after experimental myocardial infarction
S Hayashidani et al.
CIRCULATION (2003)
Medical progress: Heart failure
M Jessup et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Tissue factor deficiency cause's cardiac fibrosis and left ventricular dysfunction
R Pawlinski et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Converging pathways and principles in heart development and disease: CV@CSH
KR Chien et al.
CELL (2002)
Protease-activated receptor-2 activation causes EDHF-like coronary vasodilation - Selective preservation in ischemia/reperfusion injury: Involvement of lipoxygenase products, VR1 receptors, and C-fibers
PG McLean et al.
CIRCULATION RESEARCH (2002)
Absence of pressure overload induced myocardial hypertrophy after conditional inactivation of Gαq/Gα11 in cardiomyocytes
N Wettschureck et al.
NATURE MEDICINE (2001)
Inhibition of the tissue factor-thrombin pathway limits infarct size after myocardial ischemia-reperfusion injury by reducing inflammation
JH Erlich et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
Thrombin signalling and protease-activated receptors
SR Coughlin
NATURE (2000)
Left ventricular remodeling after myocardial infarction - Pathophysiology and therapy
MGS Sutton et al.
CIRCULATION (2000)
Signaling properties and functions of two distinct cardiomyocyte protease-activated receptors
A Sabri et al.
CIRCULATION RESEARCH (2000)
Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa
E Camerer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Protease-activated receptor-2 modulates myocardial ischemia-reperfusion injury in the rat heart
C Napoli et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
